Definitions
Sorry, no definitions found. Check out and contribute to the discussion of this word!
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word vemurafenib.
Examples
-
Roche and Daiichi Sankyo Co. of Tokyo, will provide additional data on their similar BRAF inhibitor, dubbed vemurafenib, while Bristol-Myers Squibb Co. will outline the benefits of its immune therapy Yervoy.
-
In a trial of vemurafenib, the drug improved both overall survival and progression-free survival—the time from treatment until death or disease resumption--when compared to standard chemotherapy.
Two Melanoma Drugs Prolong Survival for Some Patients Thomas Gryta 2011
-
Roche is also studying vemurafenib with its investigational a MEK inhibitor GDC-0973, in patients who previously received vemurafenib alone.
Two Melanoma Drugs Prolong Survival for Some Patients Thomas Gryta 2011
-
The drugs—Yervoy from Bristol-Myers Squibb Co., and vemurafenib from Roche Holding AG and Daiichi Sankyo Co.—use sharply different methods of treating the disease.
Two Melanoma Drugs Prolong Survival for Some Patients Thomas Gryta 2011
-
The study also found that 48.4% of those getting vemurafenib had a response compared to 5.5% of those in the chemotherapy group.
Two Melanoma Drugs Prolong Survival for Some Patients Thomas Gryta 2011
-
The drugs—Yervoy from Bristol-Myers Squibb Co., and vemurafenib from Roche Holding AG and Daiichi Sankyo Co.—use sharply different methods of treating the disease.
Two Melanoma Drugs Prolong Survival for Some Patients Thomas Gryta 2011
-
Others, such as vemurafenib for melanoma, are joining in.
The Latest Weapon Against Cancer: Evolution Matt Ridley 2011
-
Roche's vemurafenib works in a very different way, by blocking a genetic mutation known as BRAF, which may help the disease grow.
Two Melanoma Drugs Prolong Survival for Some Patients Thomas Gryta 2011
-
Roche is also studying vemurafenib with its investigational a MEK inhibitor GDC-0973, in patients who previously received vemurafenib alone.
Two Melanoma Drugs Prolong Survival for Some Patients Thomas Gryta 2011
-
The median overall survival can't be determined yet, but an estimate earlier this year showed survival of 10.5 months for patients on vemurafenib compared to 7.8 months on just chemotherapy.
Two Melanoma Drugs Prolong Survival for Some Patients Thomas Gryta 2011
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.